- Home
- FTFT vs ALLR Comparison
FTFT vs ALLR Comparison
Compare FTFT & ALLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTFT
- ALLR
- Stock Information
- Founded
- FTFT N/A
- ALLR 2004
- Country
- FTFT United States
- ALLR United States
- Employees
- FTFT N/A
- ALLR N/A
- Industry
- FTFT Business Services
- ALLR Biotechnology: Pharmaceutical Preparations
- Sector
- FTFT Consumer Discretionary
- ALLR Health Care
- Exchange
- FTFT Nasdaq
- ALLR Nasdaq
- Market Cap
- FTFT 3.9M
- ALLR 4.0M
- IPO Year
- FTFT N/A
- ALLR N/A
- Fundamental
- Price
- FTFT $1.17
- ALLR $0.85
- Analyst Decision
- FTFT
- ALLR
- Analyst Count
- FTFT 0
- ALLR 0
- Target Price
- FTFT N/A
- ALLR N/A
- AVG Volume (30 Days)
- FTFT 154.6K
- ALLR 564.6K
- Earning Date
- FTFT 05-20-2025
- ALLR 08-04-2025
- Dividend Yield
- FTFT N/A
- ALLR N/A
- EPS Growth
- FTFT N/A
- ALLR N/A
- EPS
- FTFT N/A
- ALLR N/A
- Revenue
- FTFT $2,031,913.00
- ALLR N/A
- Revenue This Year
- FTFT N/A
- ALLR N/A
- Revenue Next Year
- FTFT N/A
- ALLR N/A
- P/E Ratio
- FTFT N/A
- ALLR N/A
- Revenue Growth
- FTFT N/A
- ALLR N/A
- 52 Week Low
- FTFT $1.06
- ALLR $0.61
- 52 Week High
- FTFT $7.77
- ALLR $17.35
- Technical
- Relative Strength Index (RSI)
- FTFT 35.84
- ALLR 39.03
- Support Level
- FTFT $1.46
- ALLR $0.78
- Resistance Level
- FTFT $1.57
- ALLR $0.93
- Average True Range (ATR)
- FTFT 0.14
- ALLR 0.07
- MACD
- FTFT -0.04
- ALLR -0.02
- Stochastic Oscillator
- FTFT 15.07
- ALLR 18.72
About FTFT Future FinTech Group Inc.
Future FinTech Group Inc is engaged in the financial technology business. The company participates in supply chain financing services and trading in China, asset management business in Hong Kong, and cross-border money transfer services in the United Kingdom. It has also expanded into brokerage and investment banking business in Hong Kong and cryptocurrency mining farm in the U.S. The company's reportable segments include the Supply chain financing/trading segment which generates key revenue, and the Asset management service segment.
About ALLR Allarity Therapeutics Inc.
Allarity Therapeutics Inc is a clinical-stage, precision medicine company. The company is actively advancing a pipeline of in-licensed oncology therapeutics for patients with difficult-to-treat cancers. Its Drug Response Predictor (DRP) technology refines patient selection and improves clinical outcomes. Its pipeline product includes Dovitinib, Stenoparib, Ixempra, and other formulations.